Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Januar 2019 08:30 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Appoints Management Advisory Board

CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a...
25. Juni 2018 08:00 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue

CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
23. Juni 2018 08:00 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand

CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
29. Mai 2018 08:02 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology

CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
05. Februar 2018 08:01 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University

CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a...
01. Februar 2018 06:00 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Launches Regulation A+ (Mini-IPO) Offering; Plans to Raise $50M

CHICAGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched a...
17. Januar 2018 07:32 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Targets High Growth Healthcare 3D Printing Market as it Readies for Regulation A+ Offering

CHICAGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the high growth...
02. Januar 2018 08:01 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer

CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr....
20. Dezember 2017 09:00 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Helping Others to Give the Gift of Time this Holiday Season

CHICAGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is taking...
05. Dezember 2017 08:01 ET | Quelle: BIOLIFE4D Corporation

BIOLIFE4D Comments on New Guidelines for High Blood Pressure in Adults

CHICAGO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on a new report from...

Nächste Seite